.Attribute Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view asks for inclusion of individuals along with MASLD and also measurement of liver results in cardio-- kidney-- metabolic trials, when data recommend mechanistically probable advantages as well as clinical protection-- and lays out considerations for trial layout and also regulatory commendation.